Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 168

    1.

    Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy.

    Yee AM, Pochapin MB.

    Ann Intern Med. 2001 Jul 3;135(1):27-31.PMID: 11434729 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. A new anti-inflammatory therapy (Infliximab) for complicated sarcoidosis.

    [No authors listed]

    Ann Intern Med. 2001 Jul 3;135(1):S20. No abstract available. PMID: 11462996 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial.

    Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT; Anti-TNF Therapy Against Congestive Heart Failure Investigators.

    Circulation. 2003 Jul 1;107(25):3133-40. Epub 2003 Jun 9.PMID: 12796126 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Refractory vertebral sarcoidosis responding to infliximab.

    Garg S, Garg K, Altaf M, Magaldi JA.

    J Clin Rheumatol. 2008 Aug;14(4):238-40.PMID: 18766126 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Successful treatment with infliximab of a patient with refractory sarcoidosis]

    Fouchier SM, Möller GM, Van Santen-Hoeufft M, Faber CG, Smeenk FW, Drent M.

    Ned Tijdschr Geneeskd. 2004 Dec 4;148(49):2446-50. Dutch. PMID: 15626311 [PubMed - indexed for MEDLINE]Related articles

    8.

    Infliximab for refractory sarcoidosis.

    Baughman RP, Lower EE.

    Sarcoidosis Vasc Diffuse Lung Dis. 2001 Mar;18(1):70-4. Erratum in: Sarcoidosis Vasc Diffuse Lung Dis 2001 Oct;18(3):310. PMID: 11354550 [PubMed - indexed for MEDLINE]Related articles

    9.

    Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis.

    Ulbricht KU, Stoll M, Bierwirth J, Witte T, Schmidt RE.

    Arthritis Rheum. 2003 Dec;48(12):3542-3.PMID: 14674007 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.

    Keating GM, Perry CM.

    BioDrugs. 2002;16(2):111-48. Review.PMID: 11985485 [PubMed - indexed for MEDLINE]Related articles

    11.

    Treatment of sarcoidosis with infliximab.

    Doty JD, Mazur JE, Judson MA.

    Chest. 2005 Mar;127(3):1064-71.PMID: 15764796 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.

    Van Wijk F, Staecker H, Keithley E, Lefebvre PP.

    Audiol Neurootol. 2006;11(6):357-65. Epub 2006 Sep 21.PMID: 16988499 [PubMed - indexed for MEDLINE]Related articles

    13.

    Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature.

    Thatayatikom A, Thatayatikom S, White AJ.

    Ann Allergy Asthma Immunol. 2005 Sep;95(3):293-300.PMID: 16200822 [PubMed - indexed for MEDLINE]Related articles

    14.

    A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer.

    Brown ER, Charles KA, Hoare SA, Rye RL, Jodrell DI, Aird RE, Vora R, Prabhakar U, Nakada M, Corringham RE, DeWitte M, Sturgeon C, Propper D, Balkwill FR, Smyth JF.

    Ann Oncol. 2008 Jul;19(7):1340-6. Epub 2008 Mar 5.PMID: 18325912 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Refractory sarcoidosis responding to infliximab.

    Roberts SD, Wilkes DS, Burgett RA, Knox KS.

    Chest. 2003 Nov;124(5):2028-31.PMID: 14605086 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Tumour necrosis factor in sarcoidosis and its potential for targeted therapy.

    Baughman RP, Iannuzzi M.

    BioDrugs. 2003;17(6):425-31. Review.PMID: 14614765 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cytokine profiles during infliximab monotherapy in psoriatic arthritis.

    Mastroianni A, Minutilli E, Mussi A, Bordignon V, Trento E, D'Agosto G, Cordiali-Fei P, Berardesca E.

    Br J Dermatol. 2005 Sep;153(3):531-6.PMID: 16120138 [PubMed - indexed for MEDLINE]Related articles

    18.

    Interferon-alpha-associated sarcoidosis responsive to infliximab therapy.

    Menon Y, Cucurull E, Reisin E, Espinoza LR.

    Am J Med Sci. 2004 Sep;328(3):173-5.PMID: 15367877 [PubMed - indexed for MEDLINE]Related articles

    19.

    Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.

    Bendtzen K, Geborek P, Svenson M, Larsson L, Kapetanovic MC, Saxne T.

    Arthritis Rheum. 2006 Dec;54(12):3782-9.PMID: 17133559 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade.

    Kleinert J, Lorenz M, Köstler W, Hörl W, Sunder-Plassmann G, Soleiman A.

    Wien Klin Wochenschr. 2004 May 31;116(9-10):334-8.PMID: 15237661 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data